Ultrasonic Hemostatic Knifes Market Global Outlook, and Forecast 2022 To 2028. [MarketWatch]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: MarketWatch
The " Ultrasonic Hemostatic Knifes Market " and Industry Analysis examine the Ultrasonic Hemostatic Knifes sector internationally for the period of time from 2022 to 2028. Using specified and quantified key metrics, the market strategies, prospects, and developing trends of the Ultrasonic Hemostatic Knifes industry is studied. It has 128 number of pages in this report. The global Ultrasonic Hemostatic Knifes market size is projected to reach multi million by 2028, in comparision to 2021, at unexpected CAGR during 2022-2028 (Ask for Sample Report). Reports from market research are utilised for employee engagement surveys, competitor analysis, and to pinpoint performance or knowledge gaps and potential development areas. The market research analysis for the Ultrasonic Hemostatic Knifes market classifies the market into three divisions depending on mode: Physical, Digital, and Hybrid. Players like Ethicon,Johnson & Johnson,Misonix Inc.,Sonacare Medical,Integra LifeSciences,Alpinion
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson receives positive CHMP opinion for RYBREVANT®? (amivantamab) in combination with chemotherapy for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations [Yahoo! FinaYahoo! Fina
- Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data [Seeking Alpha]Seeking Alpha
- AACN's New Web Resource Focuses on Preparing Nurses with Essential Well-Being and Leadership Competencies [Yahoo! Finance]Yahoo! Finance
- Justice Department is investigating McKinsey consulting firm's role in opioid epidemic [CNN]CNN
- BioNJ Announces Lineup for BioPartnering Conference [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website